MITF and melanoma: Although the genomic evolution of metastasis in CM is not as clear as in other melanoma subtypes, several studies reinforce the idea that mutations in EGFR4 and NMDAR2, amplifications of MITF and MET, and loss of PTEN can be regarded as metastasis drivers [10].